The proceeds from the financing will be used "to launch the commercialization of the Veloxion System, which received U.S. Food and Drug Administration (FDA) 510(k) clearance in May 2019."
Shangbay Capital LLC Venture capital firm focused on early stage investments in the US medical device technologies, biotechnology, and mobile healthcare sectors.
